Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Novo Cure LTD Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$40.29 - $82.51 $5,277 - $10,808	131 Added 0.4%	32,961 $1.37 Million
Q1 2023 May 08, 2023	BUY	$56.44 - $118.81 $273,734 - $576,228	4,850 Added 17.33%	32,830 $1.97 Million
Q4 2022 Feb 07, 2023	BUY	$63.98 - $85.37 $2,751 - $3,670	43 Added 0.15%	27,980 $2.05 Million
Q3 2022 Nov 01, 2022	BUY	$67.99 - $89.57 $326,555 - $430,204	4,803 Added 20.76%	27,937 $2.12 Million
Q1 2022 May 09, 2022	SELL	$60.15 - $84.52 $30,676 - $43,105	-510 Reduced 2.16%	23,134 $1.92 Million
Q4 2021 Feb 07, 2022	BUY	$75.08 - $121.99 $103,310 - $167,858	1,376 Added 6.18%	23,644 $1.89 Million
Q3 2021 Nov 04, 2021	BUY	$116.17 - $194.55 $264,867 - $443,574	2,280 Added 11.41%	22,268 $2.59 Million
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $181,908 - $314,684	1,395 Added 7.5%	19,988 $4.43 Million
Q1 2021 May 06, 2021	BUY	$124.11 - $190.17 $303,697 - $465,345	2,447 Added 15.16%	18,593 $2.46 Million
Q4 2020 Feb 09, 2021	SELL	$112.16 - $174.14 $802,392 - $1.25 Million	-7,154 Reduced 30.7%	16,146 $2.79 Million
Q3 2020 Nov 10, 2020	SELL	$58.05 - $111.31 $888,165 - $1.7 Million	-15,300 Reduced 39.64%	23,300 $2.59 Million
Q2 2020 Aug 06, 2020	BUY	$57.2 - $74.41 $371,800 - $483,665	6,500 Added 20.25%	38,600 $2.29 Million
Q1 2020 May 11, 2020	BUY	$57.05 - $95.75 $735,945 - $1.24 Million	12,900 Added 67.19%	32,100 $2.16 Million
Q4 2019 Feb 05, 2020	BUY	$68.3 - $93.8 $874,240 - $1.2 Million	12,800 Added 200.0%	19,200 $1.44 Million
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $395,904 - $625,920	6,400 New	6,400 $479,000
Q4 2018 Feb 08, 2019	SELL	$28.72 - $52.63 $84,120 - $154,153	-2,929 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$32.0 - $52.4 $9,824 - $16,086	-307 Reduced 9.49%	2,929 $153,000
Q2 2018 Aug 09, 2018	SELL	$19.85 - $32.0 $5,935 - $9,568	-299 Reduced 8.46%	3,236 $101,000
Q1 2018 May 02, 2018	BUY	$19.3 - $23.65 $68,225 - $83,602	3,535 New	3,535 $77,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account